Literature DB >> 28886384

HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.

Lisa Mirabello1, Meredith Yeager2, Kai Yu3, Gary M Clifford4, Yanzi Xiao3, Bin Zhu3, Michael Cullen2, Joseph F Boland2, Nicolas Wentzensen3, Chase W Nelson5, Tina Raine-Bennett6, Zigui Chen7, Sara Bass2, Lei Song2, Qi Yang2, Mia Steinberg2, Laurie Burdett2, Michael Dean3, David Roberson2, Jason Mitchell2, Thomas Lorey8, Silvia Franceschi4, Philip E Castle9, Joan Walker10, Rosemary Zuna10, Aimée R Kreimer3, Daniel C Beachler11, Allan Hildesheim3, Paula Gonzalez12, Carolina Porras12, Robert D Burk13, Mark Schiffman3.   

Abstract

Although most cervical human papillomavirus type 16 (HPV16) infections become undetectable within 1-2 years, persistent HPV16 causes half of all cervical cancers. We used a novel HPV whole-genome sequencing technique to evaluate an exceptionally large collection of 5,570 HPV16-infected case-control samples to determine whether viral genetic variation influences risk of cervical precancer and cancer. We observed thousands of unique HPV16 genomes; very few women shared the identical HPV16 sequence, which should stimulate a careful re-evaluation of the clinical implications of HPV mutation rates, transmission, clearance, and persistence. In case-control analyses, HPV16 in the controls had significantly more amino acid changing variants throughout the genome. Strikingly, E7 was devoid of variants in precancers/cancers compared to higher levels in the controls; we confirmed this in cancers from around the world. Strict conservation of the 98 amino acids of E7, which disrupts Rb function, is critical for HPV16 carcinogenesis, presenting a highly specific target for etiologic and therapeutic research. Published by Elsevier Inc.

Entities:  

Keywords:  E7 gene; HPV epidemiology; HPV genomics; HPV16; cervical carcinogenesis

Mesh:

Substances:

Year:  2017        PMID: 28886384      PMCID: PMC5674785          DOI: 10.1016/j.cell.2017.08.001

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  77 in total

1.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

2.  Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells.

Authors:  Y Liu; J J Chen; Q Gao; S Dalal; Y Hong; C P Mansur; V Band; E J Androphy
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.

Authors:  Mark Schiffman; Sean Boyle; Tina Raine-Bennett; Hormuzd A Katki; Julia C Gage; Nicolas Wentzensen; Janet R Kornegay; Raymond Apple; Carrie Aldrich; Henry A Erlich; Thanh Tam; Brian Befano; Robert D Burk; Philip E Castle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-18       Impact factor: 4.254

4.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

Authors:  Silvia de Sanjose; Wim Gv Quint; Laia Alemany; Daan T Geraets; Jo Ellen Klaustermeier; Belen Lloveras; Sara Tous; Ana Felix; Luis Eduardo Bravo; Hai-Rim Shin; Carlos S Vallejos; Patricia Alonso de Ruiz; Marcus Aurelho Lima; Nuria Guimera; Omar Clavero; Maria Alejo; Antonio Llombart-Bosch; Chou Cheng-Yang; Silvio Alejandro Tatti; Elena Kasamatsu; Ermina Iljazovic; Michael Odida; Rodrigo Prado; Muhieddine Seoud; Magdalena Grce; Alp Usubutun; Asha Jain; Gustavo Adolfo Hernandez Suarez; Luis Estuardo Lombardi; Aekunbiola Banjo; Clara Menéndez; Efrén Javier Domingo; Julio Velasco; Ashrafun Nessa; Saibua C Bunnag Chichareon; You Lin Qiao; Enrique Lerma; Suzanne M Garland; Toshiyuki Sasagawa; Annabelle Ferrera; Doudja Hammouda; Luciano Mariani; Adela Pelayo; Ivo Steiner; Esther Oliva; Chris Jlm Meijer; Waleed Fahad Al-Jassar; Eugenia Cruz; Thomas C Wright; Ana Puras; Cecilia Ladines Llave; Maria Tzardi; Theodoros Agorastos; Victoria Garcia-Barriola; Christine Clavel; Jaume Ordi; Miguel Andújar; Xavier Castellsagué; Gloria I Sánchez; Andrzej Marcin Nowakowski; Jacob Bornstein; Nubia Muñoz; F Xavier Bosch
Journal:  Lancet Oncol       Date:  2010-10-15       Impact factor: 41.316

5.  The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.

Authors:  E R Flores; B L Allen-Hoffmann; D Lee; P F Lambert
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Philip E Castle; Diane Solomon; Robert Burk
Journal:  J Natl Cancer Inst       Date:  2008-03-25       Impact factor: 13.506

7.  Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

Authors:  Margaret R E McCredie; Katrina J Sharples; Charlotte Paul; Judith Baranyai; Gabriele Medley; Ronald W Jones; David C G Skegg
Journal:  Lancet Oncol       Date:  2008-04-11       Impact factor: 41.316

8.  Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial.

Authors:  Allan Hildesheim; Sholom Wacholder; Gregory Catteau; Frank Struyf; Gary Dubin; Rolando Herrero
Journal:  Vaccine       Date:  2014-07-10       Impact factor: 3.641

9.  Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma.

Authors:  Nicolas Wentzensen; Mark Schiffman; S Terence Dunn; Rosemary E Zuna; Joan Walker; Richard A Allen; Roy Zhang; Mark E Sherman; Sholom Wacholder; Jose Jeronimo; Michael A Gold; Sophia S Wang
Journal:  Int J Cancer       Date:  2009-02-15       Impact factor: 7.396

10.  Human papillomavirus and cervical cancer.

Authors:  Emma J Crosbie; Mark H Einstein; Silvia Franceschi; Henry C Kitchener
Journal:  Lancet       Date:  2013-04-23       Impact factor: 79.321

View more
  90 in total

1.  Genetic variations in human papillomavirus and cervical cancer outcomes.

Authors:  Janet S Rader; Shirng-Wern Tsaih; Daniel Fullin; Miriam W Murray; Marissa Iden; Michael T Zimmermann; Michael J Flister
Journal:  Int J Cancer       Date:  2019-01-04       Impact factor: 7.396

2.  Modelling the evolution of viral oncogenesis.

Authors:  Carmen Lía Murall; Samuel Alizon
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

Review 3.  Exploring the Trans-Cleavage Activity of CRISPR-Cas12a (cpf1) for the Development of a Universal Electrochemical Biosensor.

Authors:  Yifan Dai; Rodrigo A Somoza; Liu Wang; Jean F Welter; Yan Li; Arnold I Caplan; Chung Chiun Liu
Journal:  Angew Chem Int Ed Engl       Date:  2019-10-17       Impact factor: 15.336

4.  HPV+ oropharyngeal squamous cell carcinomas from patients with two tumors display synchrony of viral genomes yet discordant mutational profiles and signatures.

Authors:  Daniel L Faden; Adam Langenbucher; Krystle Kuhs; James S Lewis; Lisa Mirabello; Meredith Yeager; Joseph F Boland; Sara Bass; Mia Steinberg; Michael Cullen; Michael S Lawrence; Robert L Ferris
Journal:  Carcinogenesis       Date:  2021-02-11       Impact factor: 4.944

5.  Within-Host Variations of Human Papillomavirus Reveal APOBEC Signature Mutagenesis in the Viral Genome.

Authors:  Yusuke Hirose; Mamiko Onuki; Yuri Tenjimbayashi; Seiichiro Mori; Yoshiyuki Ishii; Takamasa Takeuchi; Nobutaka Tasaka; Toyomi Satoh; Tohru Morisada; Takashi Iwata; Shingo Miyamoto; Koji Matsumoto; Akihiko Sekizawa; Iwao Kukimoto
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

6.  The HPV16 Genome Is Stable in Women Who Progress to In Situ or Invasive Cervical Cancer: A Prospective Population-Based Study.

Authors:  Laila-Sara Arroyo-Mühr; Camilla Lagheden; Emilie Hultin; Carina Eklund; Hans-Olov Adami; Joakim Dillner; Karin Sundström
Journal:  Cancer Res       Date:  2019-07-09       Impact factor: 12.701

7.  The D2 and D3 Sublineages of Human Papilloma Virus 16-Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis.

Authors:  Hong Lou; Joseph F Boland; Edmundo Torres-Gonzalez; Anaseidy Albanez; Weiyin Zhou; Mia K Steinberg; Lena Diaw; Jason Mitchell; David Roberson; Michael Cullen; Lisa Garland; Sara Bass; Robert D Burk; Meredith Yeager; Nicolas Wentzensen; Mark Schiffman; Enrique Alvirez Freites; Eduardo Gharzouzi; Lisa Mirabello; Michael Dean
Journal:  Cancer Res       Date:  2020-07-06       Impact factor: 12.701

Review 8.  The molecular landscape of head and neck cancer.

Authors:  C René Leemans; Peter J F Snijders; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

9.  A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.

Authors:  Joshua Hatterschide; Alexis C Brantly; Miranda Grace; Karl Munger; Elizabeth A White
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

10.  Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response.

Authors:  Justine Sitz; Sophie Anne Blanchet; Steven F Gameiro; Elise Biquand; Tia M Morgan; Maxime Galloy; Julien Dessapt; Elise G Lavoie; Andréanne Blondeau; Brandon C Smith; Joe S Mymryk; Cary A Moody; Amélie Fradet-Turcotte
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.